Table 2. Surgical findings and postoperative outcomes of HIPEC (n=27).
| Variables | Values | |
|---|---|---|
| PCI (median and range) | 8 (1–16) | |
| Tumor burden* | ||
| Low (PIV ≤2) | 7 (25.9) | |
| Intermediate (PIV 4–6) | 14 (51.9) | |
| High (PIV ≥8) | 6 (22.2) | |
| Estimated blood loss (L) | ||
| ≤1 | 15 (55.6) | |
| 1–2 | 10 (37.0) | |
| 2–4 | 2 (7.4) | |
| Intraoperative blood transfusion (units) | ||
| None | 8 (29.6) | |
| 1–2 | 10 (37.0) | |
| 3–4 | 5 (18.6) | |
| ≥5 | 4 (14.8) | |
| Operative time (min) | 543.8 (277.0–915.0) | |
| Complication grade† | ||
| 0 | 8 (29.6) | |
| 1 | 5 (18.6) | |
| 2 | 9 (33.3) | |
| 3 | 4 (14.8) | |
| 4 | 1 (3.7) | |
| 5 | 0 (0) | |
| Length of hospitalization (days) | 18.7 (5.0–131.0) | |
Values are presented as median (range) or number of patients (%).
HIPEC, hyperthermic intraperitoneal chemotherapy; PCI, peritoneal cancer index; PIV, predictive index value
*According to Fagotti et al. [8]; †According to the Memorial Sloan-Kettering Cancer Center surgical secondary events grading system [9].